Study of interaction between ibuprofen and nicotinamide using differential scanning calorimetry, spectroscopy, and microscopy and formulation of a fast-acting and possibly better ibuprofen suspension for osteoarthritis patients

Journal of Pharmaceutical Sciences

Volumn 94, Issue 1, 2005, Pages 93-101

  Oberoi, Lalit M ^a   Alexander, Kenneth S ^a   Riga, Alan T ^a,b  

^a UNIVERSITY OF TOLEDO   (United States)

^b CLEVELAND STATE UNIVERSITY   (United States)

Author keywords

Complexation; HPLC (high performance pressure liquid chromatography); Microscopy; Solubility; Spectroscopy; Thermal analysis

Indexed keywords

IBUPROFEN; NICOTINAMIDE;

ANALGESIA; ARTICLE; CHEMICAL COMPOSITION; CHEMICAL INTERACTION; COMPLEX FORMATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROSCOPY; MELTING POINT; MICROCRYSTALLINE SUSPENSION; MICROSCOPY; NUCLEAR MAGNETIC RESONANCE; OSTEOARTHRITIS; PARTICLE SIZE; PROTON NUCLEAR MAGNETIC RESONANCE; SOLID STATE; SOLVENT EFFECT; SOLVENT EVAPORATION METHOD; SPECTROSCOPY; STOICHIOMETRY; THERMAL ANALYSIS; ULTRAVIOLET SPECTROSCOPY; X RAY POWDER DIFFRACTION;

EID: 12244252266     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.20223     Document Type: Article

References (23)

1. Leuenberger H. 2002. Spray freeze-drying: The process of choice for low water soluble drugs? J Nanopart Res 4:111-119.
2. Stenberg P, Bergstrom CAS, Luthman K, Artursson P. 2002. Theoretical predictions of drug absorption in drug discovery and development. Clin Pharmacokinetics 41(11):877-899.
3. Neuberg C. 1916. Hydrotropy. Biochem Z 76:107-176.
4. Saleh AM, El-Khordagui LK. 1985. Hydrotropic agents: A new definition. Int J Pharm 24:231-238.
5. Coffman RE, Kildsig D. 1996, Hydrotropic solubilization: Mechanistic studies. Pharm Res 13(10): 1460-1463.
6. Lee J, Lee SC, Acharya G, Chang C, Park K. 2003. Hydrotropic solubilization of paclitaxel: Analysis of chemical structures for hydrotropic property. Pharm Res 20(7):1022-1030.
7. Truelove J, Bawarshi-Nassar R, Chen NR, Hussain A. 1984. Solubility enhancement of some developmental anti-cancer nucleoside analogs by complexation with nicotinamide. Int J Pharm 19:17-25.
8. Suzuki H, Sunada H. 1998. Mechanistic studies on hydrotropic solubilization of nifedipine in nicotinamide solution. Chem Pharm Bull 46(1):125-130.
9. Rasool AA, Hussain AA, Dittert LW. 1991. Solubility enhancement of some water insoluble drugs in the presence of nicotinamide and related compounds. J Pharm Sci 80(4):387-393.
10. Kenley RA, Jackson SE, Winterle JS, Shunko Y. 1986. Water soluble complexes of the antiviral drugs, 9-[(1,3-diydroxy-2-propoxy)methyl]guanine and acyclovir: The role of hydrophobicity in complex formation. J Pharm Sci 75(7):648-653.
11. Yalkowsky SH. 1999. Solubility and solubilization in aqueous media. New York: Oxford University Press, pp 360-373.
12. http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/nic_0183. shtml. PDR health, accessed on December 5, 2003.
13. Tripathi KD. 2001. Essentials of medical pharmacology. 4th ed. New Delhi: Medical Publishers, p 461.
14. Stuhlmeier KM, Li H, Kao JJ. 1999. Ibuprofen: New explanation for an old phenomenon. Biochem Pharmacol 57:313-320.
15. Earl RT, Jenkins R, Munro AJ. 1996. A double-masked comparison of the efficacy of once-daily sustained-release ibuprofen and once-daily piroxicam for 24-hour control of arthralgia due to osteoarthritis in the elderly. Curr Ther Res 57(10):811-821.
16. Codispoti JR, Prior MJ, Fu M, Harte CM, Nelson EB. 2001. Efficacy of nonprescription doses of ibuprofen for treating migraine headache: A randomized controlled trial. Headache 41:665-679.
17. Moschiano F, Grazzi L, D'Amico D, Schieroni F, Bussone G. 2001. Menstrual migraine. J Headache Pain 2:S117-S119.
18. Desjardins P, Black P, Papageorge M, Norwood T, Shen DD, Norris L, Ardia A. 2002. Ibuprofen arginate provides effective relief from postoperative dental pain with a more rapid onset of action than ibuprofen. Eur J Clin Pharmacol 58:387-394.
19. Moore N, Ganse EV, Le Parc JM, Wall R, Schneid H, Farhan M, Verriere F, Pelen F. 1999. The PAIN study: Paracetamol, aspirin and ibuprofen new tolerability study. Clin Drug Invest 18(2):89-98.
20. Habib MJ. 2001. Pharmaceutical solid dispersion technology. Lancaster, PA: Technomic Publishing, p 22.
21. Passerini N, Albertini B, Gonzalez-Rodriguez ML, Cavallari C, Rodriguez L. 2002. Preparation and characterisation of ibuprofen-poloxamer 188 granules obtained by melt granulation. Eur J Pharm Sci 15:71-78.
22. Phadnis NV, Suryanarayanan R. 1997. Simultaneous quantification of an enantiomer and the racemic compound of ibuprofen by X-ray powder diffractometry. Pharm Res 14(9):1176-1180.
23. Kindberg BL. 1977. X-ray crystal and molecular structure of {Cu(nicotinamide)2(H2O)2(BF4)2..2H2O}. J Chem Soc Chem Commun 13:461.